Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphatic Metastasis | 48 | 2022 | 2914 | 4.590 |
Why?
|
Ferrosoferric Oxide | 29 | 2021 | 348 | 3.930 |
Why?
|
Magnetic Resonance Imaging | 125 | 2024 | 36743 | 3.880 |
Why?
|
Prostatic Neoplasms | 56 | 2024 | 11101 | 3.650 |
Why?
|
Rectal Neoplasms | 14 | 2023 | 1183 | 3.370 |
Why?
|
Lymph Nodes | 32 | 2020 | 3474 | 3.250 |
Why?
|
Contrast Media | 64 | 2023 | 5330 | 3.000 |
Why?
|
Oxides | 18 | 2009 | 403 | 2.630 |
Why?
|
Prostate | 25 | 2024 | 1765 | 2.220 |
Why?
|
Pelvic Neoplasms | 6 | 2020 | 250 | 2.090 |
Why?
|
Diagnostic Imaging | 19 | 2021 | 3533 | 1.970 |
Why?
|
Image Enhancement | 19 | 2019 | 2880 | 1.740 |
Why?
|
Tomography, X-Ray Computed | 57 | 2024 | 20760 | 1.650 |
Why?
|
Diffusion Magnetic Resonance Imaging | 9 | 2024 | 2815 | 1.650 |
Why?
|
Iron | 18 | 2009 | 1813 | 1.620 |
Why?
|
Dextrans | 22 | 2010 | 574 | 1.560 |
Why?
|
Neoplasm Staging | 40 | 2024 | 11244 | 1.460 |
Why?
|
Abdominal Neoplasms | 4 | 2020 | 287 | 1.400 |
Why?
|
Pelvis | 12 | 2020 | 736 | 1.330 |
Why?
|
Nanoparticles | 15 | 2016 | 1985 | 1.260 |
Why?
|
Magnetite Nanoparticles | 22 | 2014 | 312 | 1.220 |
Why?
|
Sensitivity and Specificity | 51 | 2020 | 14729 | 1.180 |
Why?
|
Lymphatic Diseases | 3 | 2015 | 319 | 1.160 |
Why?
|
Rectal Fistula | 2 | 2019 | 76 | 1.150 |
Why?
|
Anus Neoplasms | 4 | 2022 | 336 | 1.150 |
Why?
|
Cholangiocarcinoma | 4 | 2022 | 561 | 1.100 |
Why?
|
Penile Neoplasms | 5 | 2014 | 158 | 1.000 |
Why?
|
Rectum | 7 | 2023 | 900 | 0.990 |
Why?
|
Kidney Neoplasms | 14 | 2024 | 4282 | 0.880 |
Why?
|
Abdomen | 7 | 2020 | 1136 | 0.880 |
Why?
|
Male Urogenital Diseases | 2 | 2014 | 48 | 0.870 |
Why?
|
Radiology | 12 | 2023 | 2104 | 0.850 |
Why?
|
Peritoneal Neoplasms | 2 | 2022 | 714 | 0.850 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2022 | 195 | 0.840 |
Why?
|
Lymphography | 5 | 2019 | 189 | 0.830 |
Why?
|
Radiology Information Systems | 4 | 2020 | 533 | 0.830 |
Why?
|
Testicular Neoplasms | 4 | 2015 | 806 | 0.810 |
Why?
|
Diagnosis, Differential | 40 | 2024 | 13014 | 0.780 |
Why?
|
Lymphoma | 5 | 2017 | 1898 | 0.780 |
Why?
|
Positron-Emission Tomography | 15 | 2024 | 6669 | 0.750 |
Why?
|
Teratoma | 1 | 2024 | 405 | 0.750 |
Why?
|
Humans | 239 | 2024 | 768166 | 0.740 |
Why?
|
Male | 151 | 2024 | 364719 | 0.740 |
Why?
|
Peer Review, Research | 2 | 2015 | 344 | 0.720 |
Why?
|
Heart Neoplasms | 1 | 2024 | 374 | 0.720 |
Why?
|
Prostatitis | 1 | 2021 | 102 | 0.710 |
Why?
|
Angiomyolipoma | 3 | 2020 | 189 | 0.680 |
Why?
|
Adenocarcinoma | 11 | 2017 | 6395 | 0.680 |
Why?
|
Anal Canal | 3 | 2019 | 376 | 0.670 |
Why?
|
Bile Duct Neoplasms | 3 | 2022 | 614 | 0.670 |
Why?
|
Ultrasonography, Interventional | 9 | 2021 | 1523 | 0.670 |
Why?
|
Carcinoma, Renal Cell | 8 | 2018 | 3187 | 0.650 |
Why?
|
Fluorodeoxyglucose F18 | 6 | 2020 | 2055 | 0.640 |
Why?
|
Urinary Bladder Neoplasms | 8 | 2019 | 2195 | 0.630 |
Why?
|
Fistula | 2 | 2018 | 213 | 0.620 |
Why?
|
Retrospective Studies | 49 | 2024 | 81762 | 0.610 |
Why?
|
Radiopharmaceuticals | 8 | 2020 | 2735 | 0.600 |
Why?
|
Aged | 81 | 2024 | 171504 | 0.580 |
Why?
|
Middle Aged | 95 | 2024 | 223492 | 0.570 |
Why?
|
Adrenal Glands | 3 | 2013 | 557 | 0.570 |
Why?
|
Image Interpretation, Computer-Assisted | 10 | 2024 | 3390 | 0.560 |
Why?
|
Radiotherapy, Conformal | 3 | 2018 | 549 | 0.560 |
Why?
|
Fatty Liver | 1 | 2023 | 809 | 0.560 |
Why?
|
Crohn Disease | 4 | 2017 | 2295 | 0.560 |
Why?
|
Rectal Diseases | 1 | 2018 | 142 | 0.550 |
Why?
|
Radiography, Abdominal | 4 | 2015 | 541 | 0.540 |
Why?
|
Pleural Neoplasms | 1 | 2021 | 612 | 0.530 |
Why?
|
Urogenital Neoplasms | 2 | 2008 | 130 | 0.510 |
Why?
|
Reproducibility of Results | 23 | 2022 | 20227 | 0.510 |
Why?
|
Pancreatic Neoplasms | 6 | 2024 | 5446 | 0.510 |
Why?
|
Nanostructures | 6 | 2006 | 553 | 0.490 |
Why?
|
Radiography, Interventional | 7 | 2012 | 1131 | 0.490 |
Why?
|
Mesothelioma | 1 | 2021 | 811 | 0.480 |
Why?
|
alpha-Fetoproteins | 1 | 2015 | 229 | 0.480 |
Why?
|
Gadolinium DTPA | 6 | 2019 | 823 | 0.480 |
Why?
|
Biopsy, Needle | 6 | 2018 | 1622 | 0.460 |
Why?
|
Urinary Reservoirs, Continent | 1 | 2014 | 29 | 0.460 |
Why?
|
Urogenital Surgical Procedures | 1 | 2014 | 34 | 0.450 |
Why?
|
Ganglia, Sympathetic | 1 | 2014 | 65 | 0.450 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 515 | 0.440 |
Why?
|
Prostatectomy | 12 | 2023 | 1786 | 0.440 |
Why?
|
Urinary Diversion | 1 | 2014 | 134 | 0.430 |
Why?
|
Writing | 1 | 2015 | 200 | 0.430 |
Why?
|
Diverticulitis, Colonic | 2 | 2013 | 139 | 0.430 |
Why?
|
Blood Coagulation Disorders | 1 | 2016 | 350 | 0.430 |
Why?
|
Portal Vein | 2 | 2015 | 435 | 0.420 |
Why?
|
Periodicals as Topic | 2 | 2015 | 1465 | 0.420 |
Why?
|
Aged, 80 and over | 34 | 2023 | 59629 | 0.410 |
Why?
|
Tomography, Emission-Computed | 4 | 2009 | 1126 | 0.410 |
Why?
|
Viscera | 1 | 2013 | 138 | 0.400 |
Why?
|
Infectious Mononucleosis | 1 | 2013 | 133 | 0.400 |
Why?
|
Urinary Bladder | 3 | 2014 | 1157 | 0.400 |
Why?
|
Neovascularization, Pathologic | 2 | 2013 | 2631 | 0.400 |
Why?
|
Vena Cava, Inferior | 1 | 2015 | 463 | 0.400 |
Why?
|
Female | 99 | 2024 | 397192 | 0.390 |
Why?
|
Aorta | 2 | 2024 | 2045 | 0.390 |
Why?
|
Digestive System Diseases | 1 | 2013 | 152 | 0.380 |
Why?
|
Predictive Value of Tests | 18 | 2023 | 15454 | 0.380 |
Why?
|
Drainage | 5 | 2005 | 1183 | 0.370 |
Why?
|
Colorectal Neoplasms | 2 | 2021 | 6974 | 0.360 |
Why?
|
Tomography, Spiral Computed | 2 | 2010 | 273 | 0.360 |
Why?
|
Biopsy | 13 | 2023 | 6793 | 0.350 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2020 | 2059 | 0.350 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 498 | 0.350 |
Why?
|
Adult | 64 | 2023 | 223646 | 0.350 |
Why?
|
Workflow | 1 | 2015 | 860 | 0.350 |
Why?
|
Liver | 9 | 2023 | 7577 | 0.340 |
Why?
|
Ferric Compounds | 4 | 2010 | 376 | 0.340 |
Why?
|
Whole Body Imaging | 2 | 2022 | 284 | 0.340 |
Why?
|
Multimedia | 1 | 2010 | 76 | 0.340 |
Why?
|
Androgen Antagonists | 1 | 2018 | 1412 | 0.330 |
Why?
|
Liver Neoplasms | 11 | 2016 | 4362 | 0.330 |
Why?
|
Workload | 1 | 2015 | 849 | 0.320 |
Why?
|
Gastrointestinal Diseases | 2 | 2020 | 1206 | 0.320 |
Why?
|
Ultrasonography, Prenatal | 5 | 2016 | 1772 | 0.320 |
Why?
|
Kidney Diseases | 3 | 2016 | 2100 | 0.310 |
Why?
|
Diagnostic Errors | 2 | 2014 | 1281 | 0.310 |
Why?
|
Hemangioma | 6 | 2016 | 727 | 0.300 |
Why?
|
Neoplasms, Second Primary | 2 | 2016 | 1061 | 0.300 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2420 | 0.290 |
Why?
|
Ureteral Neoplasms | 2 | 2024 | 107 | 0.290 |
Why?
|
Adipose Tissue | 3 | 2012 | 3329 | 0.290 |
Why?
|
Intestines | 4 | 2011 | 1909 | 0.290 |
Why?
|
Lung Neoplasms | 4 | 2021 | 13586 | 0.280 |
Why?
|
Colonoscopy | 2 | 2013 | 1409 | 0.280 |
Why?
|
Prostate-Specific Antigen | 7 | 2023 | 2463 | 0.280 |
Why?
|
Subtraction Technique | 1 | 2010 | 517 | 0.270 |
Why?
|
Collagen | 2 | 2019 | 2643 | 0.270 |
Why?
|
Autoimmune Diseases | 3 | 2020 | 2257 | 0.270 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2013 | 617 | 0.260 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1757 | 0.260 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2024 | 9015 | 0.250 |
Why?
|
Hemorrhage | 2 | 2021 | 3467 | 0.250 |
Why?
|
Tuberculosis | 2 | 2014 | 2029 | 0.250 |
Why?
|
Neoplasms | 9 | 2023 | 22371 | 0.240 |
Why?
|
Kidney Diseases, Cystic | 2 | 2005 | 182 | 0.240 |
Why?
|
Abdominal Abscess | 2 | 2004 | 153 | 0.240 |
Why?
|
Radiology Department, Hospital | 2 | 2010 | 409 | 0.240 |
Why?
|
Biopsy, Fine-Needle | 1 | 2009 | 1135 | 0.230 |
Why?
|
Immunoglobulin G | 3 | 2024 | 4568 | 0.230 |
Why?
|
Inflammation | 5 | 2024 | 10873 | 0.230 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2022 | 304 | 0.230 |
Why?
|
Adrenal Gland Neoplasms | 4 | 2008 | 735 | 0.220 |
Why?
|
Colonography, Computed Tomographic | 1 | 2005 | 170 | 0.220 |
Why?
|
Magnetic Resonance Angiography | 2 | 2021 | 1429 | 0.210 |
Why?
|
Urography | 1 | 2024 | 316 | 0.210 |
Why?
|
Abscess | 2 | 2004 | 606 | 0.210 |
Why?
|
Tuberous Sclerosis | 3 | 2020 | 1042 | 0.210 |
Why?
|
Colonic Neoplasms | 2 | 2013 | 2541 | 0.210 |
Why?
|
Neuroendocrine Tumors | 2 | 2024 | 659 | 0.200 |
Why?
|
Observer Variation | 4 | 2020 | 2622 | 0.200 |
Why?
|
Radiography | 3 | 2010 | 6983 | 0.200 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2011 | 2442 | 0.200 |
Why?
|
Ileum | 2 | 2009 | 558 | 0.200 |
Why?
|
Ovarian Neoplasms | 2 | 2016 | 4916 | 0.200 |
Why?
|
Thyroid Nodule | 1 | 2009 | 767 | 0.200 |
Why?
|
Simethicone | 2 | 2003 | 15 | 0.200 |
Why?
|
Endometriosis | 2 | 2024 | 873 | 0.200 |
Why?
|
Esophageal Neoplasms | 2 | 2009 | 1668 | 0.200 |
Why?
|
Uterine Hemorrhage | 2 | 2013 | 236 | 0.190 |
Why?
|
Hepatitis | 2 | 2014 | 227 | 0.190 |
Why?
|
Ultrasonography | 8 | 2023 | 6004 | 0.190 |
Why?
|
Gallbladder Neoplasms | 1 | 2023 | 190 | 0.190 |
Why?
|
Polyps | 1 | 2023 | 200 | 0.190 |
Why?
|
Cellulose | 2 | 2003 | 117 | 0.190 |
Why?
|
Prognosis | 8 | 2022 | 30010 | 0.190 |
Why?
|
Colonic Diseases | 1 | 2003 | 204 | 0.190 |
Why?
|
Lymph Node Excision | 4 | 2019 | 1271 | 0.190 |
Why?
|
Splenic Diseases | 1 | 2001 | 91 | 0.180 |
Why?
|
Iopamidol | 3 | 2016 | 187 | 0.180 |
Why?
|
Intestinal Diseases | 2 | 2022 | 505 | 0.180 |
Why?
|
Diverticulum | 2 | 2019 | 137 | 0.180 |
Why?
|
Medical Oncology | 5 | 2023 | 2346 | 0.180 |
Why?
|
Giant Cell Tumors | 1 | 2020 | 89 | 0.170 |
Why?
|
Computers | 1 | 2022 | 592 | 0.170 |
Why?
|
Tumor Suppressor Proteins | 3 | 2018 | 2810 | 0.170 |
Why?
|
Adenoma, Liver Cell | 2 | 2014 | 32 | 0.170 |
Why?
|
Incidental Findings | 3 | 2013 | 698 | 0.170 |
Why?
|
Penis | 4 | 2014 | 209 | 0.160 |
Why?
|
Syndrome | 2 | 2024 | 3272 | 0.160 |
Why?
|
Urethral Diseases | 1 | 2019 | 52 | 0.160 |
Why?
|
Surgical Mesh | 2 | 2014 | 315 | 0.160 |
Why?
|
Prospective Studies | 18 | 2024 | 54926 | 0.160 |
Why?
|
Kidney Calculi | 1 | 2003 | 458 | 0.160 |
Why?
|
Reference Values | 2 | 2019 | 4938 | 0.160 |
Why?
|
Watchful Waiting | 1 | 2023 | 492 | 0.160 |
Why?
|
Abdominal Injuries | 1 | 2022 | 362 | 0.160 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 1926 | 0.160 |
Why?
|
Software | 1 | 2013 | 4478 | 0.150 |
Why?
|
ROC Curve | 6 | 2013 | 3628 | 0.150 |
Why?
|
Preoperative Care | 6 | 2012 | 2258 | 0.150 |
Why?
|
Cannabidiol | 1 | 2020 | 123 | 0.150 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1232 | 0.150 |
Why?
|
World Health Organization | 1 | 2024 | 1329 | 0.140 |
Why?
|
Nanotechnology | 1 | 2003 | 714 | 0.140 |
Why?
|
Young Adult | 10 | 2020 | 60066 | 0.140 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2023 | 672 | 0.140 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2018 | 40 | 0.140 |
Why?
|
Workplace | 1 | 2004 | 873 | 0.140 |
Why?
|
Urinary Incontinence, Stress | 1 | 2019 | 180 | 0.140 |
Why?
|
Lymphatic Irradiation | 2 | 2009 | 115 | 0.140 |
Why?
|
Evaluation Studies as Topic | 2 | 2019 | 1627 | 0.140 |
Why?
|
Triage | 1 | 2024 | 997 | 0.140 |
Why?
|
Liver Diseases | 3 | 2021 | 1305 | 0.140 |
Why?
|
Obstetrics | 2 | 2014 | 681 | 0.140 |
Why?
|
Adolescent | 18 | 2022 | 89169 | 0.140 |
Why?
|
Pilot Projects | 5 | 2015 | 8741 | 0.140 |
Why?
|
Referral and Consultation | 1 | 2010 | 3620 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2014 | 2357 | 0.140 |
Why?
|
Societies, Medical | 3 | 2019 | 3968 | 0.140 |
Why?
|
Radiographic Image Enhancement | 2 | 2015 | 877 | 0.140 |
Why?
|
Intussusception | 2 | 2008 | 116 | 0.130 |
Why?
|
Gadolinium | 3 | 2023 | 964 | 0.130 |
Why?
|
Carcinoma, Transitional Cell | 3 | 2024 | 794 | 0.130 |
Why?
|
Cysts | 3 | 2019 | 685 | 0.130 |
Why?
|
Practice Guidelines as Topic | 7 | 2015 | 7454 | 0.130 |
Why?
|
Bile Duct Diseases | 2 | 2007 | 98 | 0.130 |
Why?
|
Colon | 1 | 2003 | 1801 | 0.120 |
Why?
|
Spleen | 1 | 2001 | 2295 | 0.120 |
Why?
|
Adenoma | 2 | 2003 | 2159 | 0.120 |
Why?
|
Pancreas | 3 | 2020 | 1700 | 0.120 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2021 | 798 | 0.120 |
Why?
|
Hematuria | 2 | 2013 | 232 | 0.120 |
Why?
|
Evidence-Based Medicine | 4 | 2016 | 3706 | 0.120 |
Why?
|
Fallopian Tube Diseases | 1 | 2015 | 60 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1008 | 0.120 |
Why?
|
Pregnancy Complications | 3 | 2013 | 2973 | 0.120 |
Why?
|
Nephrectomy | 3 | 2009 | 930 | 0.120 |
Why?
|
Fetal Death | 1 | 2016 | 434 | 0.120 |
Why?
|
Ureter | 2 | 2024 | 364 | 0.120 |
Why?
|
Neoplasm Metastasis | 5 | 2010 | 4912 | 0.120 |
Why?
|
Disease Progression | 3 | 2023 | 13671 | 0.120 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2014 | 29 | 0.120 |
Why?
|
Algorithms | 5 | 2024 | 14164 | 0.120 |
Why?
|
CA-125 Antigen | 1 | 2016 | 281 | 0.110 |
Why?
|
Internship and Residency | 1 | 2014 | 5953 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2019 | 905 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 406 | 0.110 |
Why?
|
Kidney | 5 | 2021 | 7064 | 0.110 |
Why?
|
Consensus | 2 | 2020 | 3212 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2014 | 4058 | 0.110 |
Why?
|
Combined Modality Therapy | 6 | 2018 | 8542 | 0.110 |
Why?
|
Splenic Neoplasms | 1 | 2013 | 97 | 0.110 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2013 | 16 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2023 | 3780 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 788 | 0.110 |
Why?
|
Carcinoma, Ductal | 1 | 2013 | 97 | 0.100 |
Why?
|
Buttocks | 2 | 2003 | 111 | 0.100 |
Why?
|
Boston | 3 | 2016 | 9374 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1542 | 0.100 |
Why?
|
Splenomegaly | 1 | 2013 | 192 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2018 | 1070 | 0.100 |
Why?
|
Adnexal Diseases | 1 | 2013 | 104 | 0.100 |
Why?
|
Kidney Function Tests | 1 | 2014 | 684 | 0.100 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 139 | 0.100 |
Why?
|
Seminoma | 1 | 2013 | 136 | 0.100 |
Why?
|
Intestine, Small | 2 | 2011 | 1217 | 0.090 |
Why?
|
Neoplasm Invasiveness | 3 | 2021 | 3620 | 0.090 |
Why?
|
Urethral Neoplasms | 1 | 2011 | 37 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2013 | 9419 | 0.090 |
Why?
|
Pregnancy Trimester, Third | 1 | 2013 | 587 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5432 | 0.090 |
Why?
|
Treatment Outcome | 7 | 2020 | 65371 | 0.090 |
Why?
|
Pregnancy Trimester, Second | 1 | 2013 | 737 | 0.090 |
Why?
|
Urethra | 2 | 2011 | 406 | 0.090 |
Why?
|
Polypropylenes | 1 | 2010 | 63 | 0.090 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 383 | 0.090 |
Why?
|
Pancreatic Diseases | 2 | 2007 | 354 | 0.090 |
Why?
|
Urinary Incontinence | 2 | 2006 | 490 | 0.090 |
Why?
|
Catheterization | 3 | 2005 | 1430 | 0.090 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2010 | 42 | 0.090 |
Why?
|
Microscopy, Electron | 2 | 2018 | 2560 | 0.090 |
Why?
|
Causality | 1 | 2016 | 1254 | 0.090 |
Why?
|
Thrombotic Microangiopathies | 1 | 2011 | 124 | 0.090 |
Why?
|
Urology | 1 | 2014 | 384 | 0.080 |
Why?
|
Radiation Dosage | 2 | 2015 | 1967 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 826 | 0.080 |
Why?
|
Automation | 2 | 2018 | 589 | 0.080 |
Why?
|
Fetal Growth Retardation | 1 | 2013 | 592 | 0.080 |
Why?
|
Injections, Intravenous | 2 | 2010 | 1377 | 0.080 |
Why?
|
Survival Rate | 2 | 2016 | 12840 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 2 | 2010 | 2056 | 0.080 |
Why?
|
Surgery, Computer-Assisted | 2 | 2009 | 1003 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 763 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2009 | 2862 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2002 | 2333 | 0.080 |
Why?
|
Pregnancy Trimester, First | 1 | 2013 | 917 | 0.080 |
Why?
|
Neoadjuvant Therapy | 3 | 2021 | 2907 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39348 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 4 | 2016 | 4063 | 0.080 |
Why?
|
Kidney Pelvis | 1 | 2009 | 191 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2015 | 3447 | 0.070 |
Why?
|
Critical Illness | 1 | 2021 | 2756 | 0.070 |
Why?
|
Tissue Distribution | 3 | 2014 | 2300 | 0.070 |
Why?
|
Meglumine | 2 | 1999 | 144 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3436 | 0.070 |
Why?
|
Scleroderma, Systemic | 1 | 2011 | 346 | 0.070 |
Why?
|
Hernia, Inguinal | 1 | 2010 | 224 | 0.070 |
Why?
|
False Positive Reactions | 2 | 2014 | 963 | 0.070 |
Why?
|
History, 19th Century | 1 | 2010 | 714 | 0.070 |
Why?
|
Employment | 1 | 2014 | 1110 | 0.070 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2011 | 542 | 0.070 |
Why?
|
Fetal Diseases | 1 | 2012 | 916 | 0.070 |
Why?
|
Comorbidity | 2 | 2023 | 10590 | 0.070 |
Why?
|
Cystoscopy | 1 | 2006 | 128 | 0.070 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2007 | 100 | 0.070 |
Why?
|
Urologic Diseases | 1 | 2009 | 246 | 0.070 |
Why?
|
Cohort Studies | 5 | 2023 | 41754 | 0.070 |
Why?
|
Particle Size | 2 | 2003 | 1649 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2011 | 812 | 0.060 |
Why?
|
Bile Ducts | 1 | 2007 | 288 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4528 | 0.060 |
Why?
|
Cell Hypoxia | 1 | 2008 | 662 | 0.060 |
Why?
|
Efficiency, Organizational | 1 | 2010 | 697 | 0.060 |
Why?
|
Magnetics | 2 | 2010 | 597 | 0.060 |
Why?
|
Incidence | 5 | 2021 | 21538 | 0.060 |
Why?
|
Prevalence | 3 | 2016 | 15869 | 0.060 |
Why?
|
Cholecystostomy | 1 | 2005 | 54 | 0.060 |
Why?
|
Medical Illustration | 1 | 2006 | 135 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2830 | 0.060 |
Why?
|
Cryosurgery | 1 | 2010 | 479 | 0.060 |
Why?
|
Pancreatic Ducts | 1 | 2007 | 330 | 0.060 |
Why?
|
Gastrointestinal Tract | 1 | 2011 | 840 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11095 | 0.060 |
Why?
|
Costs and Cost Analysis | 1 | 2010 | 1667 | 0.060 |
Why?
|
Pelvic Infection | 1 | 2004 | 12 | 0.060 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 4 | 2021 | 1679 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10101 | 0.060 |
Why?
|
Office Automation | 1 | 2004 | 14 | 0.060 |
Why?
|
Organometallic Compounds | 2 | 1999 | 648 | 0.060 |
Why?
|
Asthenopia | 1 | 2004 | 12 | 0.060 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1351 | 0.060 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2004 | 139 | 0.060 |
Why?
|
Man-Machine Systems | 1 | 2004 | 42 | 0.060 |
Why?
|
Computer Terminals | 1 | 2004 | 41 | 0.060 |
Why?
|
Interior Design and Furnishings | 1 | 2004 | 34 | 0.060 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2008 | 737 | 0.060 |
Why?
|
Adrenal Medulla | 1 | 2003 | 56 | 0.060 |
Why?
|
Acute Disease | 2 | 2013 | 7243 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1573 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6568 | 0.060 |
Why?
|
Documentation | 1 | 2010 | 917 | 0.050 |
Why?
|
Brachytherapy | 1 | 2011 | 1220 | 0.050 |
Why?
|
Embolism, Air | 1 | 2003 | 110 | 0.050 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2005 | 260 | 0.050 |
Why?
|
Rupture, Spontaneous | 1 | 2003 | 365 | 0.050 |
Why?
|
Salvage Therapy | 1 | 2009 | 1273 | 0.050 |
Why?
|
Leuprolide | 1 | 2004 | 313 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2018 | 22291 | 0.050 |
Why?
|
Enteritis | 1 | 2003 | 164 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Computer Systems | 1 | 2004 | 469 | 0.050 |
Why?
|
Cumulative Trauma Disorders | 1 | 2004 | 152 | 0.050 |
Why?
|
Aneurysm, False | 1 | 2005 | 263 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 2008 | 0.050 |
Why?
|
Digestive System | 1 | 2003 | 244 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Thorax | 1 | 2005 | 557 | 0.050 |
Why?
|
Colchicine | 1 | 2003 | 257 | 0.050 |
Why?
|
Radiology, Interventional | 1 | 2006 | 483 | 0.050 |
Why?
|
Mycoses | 1 | 2005 | 386 | 0.050 |
Why?
|
Risk Factors | 3 | 2019 | 74944 | 0.050 |
Why?
|
Lighting | 1 | 2004 | 210 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2766 | 0.050 |
Why?
|
Gout Suppressants | 1 | 2003 | 176 | 0.050 |
Why?
|
Hyperplasia | 2 | 2003 | 1151 | 0.050 |
Why?
|
Pyrroles | 1 | 2008 | 1124 | 0.050 |
Why?
|
United States | 10 | 2023 | 73039 | 0.050 |
Why?
|
Carcinoma, Lobular | 1 | 2006 | 480 | 0.050 |
Why?
|
Postoperative Complications | 5 | 2010 | 15832 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2023 | 300 | 0.050 |
Why?
|
Pheochromocytoma | 1 | 2003 | 328 | 0.050 |
Why?
|
Registries | 1 | 2017 | 8375 | 0.050 |
Why?
|
Diverticulitis | 1 | 2003 | 187 | 0.040 |
Why?
|
Tuberculosis, Urogenital | 1 | 2000 | 9 | 0.040 |
Why?
|
Tuberculosis, Spinal | 1 | 2000 | 16 | 0.040 |
Why?
|
Spondylitis | 1 | 2000 | 20 | 0.040 |
Why?
|
Tuberculosis, Gastrointestinal | 1 | 2000 | 20 | 0.040 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2000 | 17 | 0.040 |
Why?
|
Tuberculosis, Osteoarticular | 1 | 2000 | 26 | 0.040 |
Why?
|
Child | 7 | 2015 | 80917 | 0.040 |
Why?
|
Massachusetts | 2 | 2011 | 8890 | 0.040 |
Why?
|
Perineum | 1 | 2021 | 212 | 0.040 |
Why?
|
Risk Assessment | 3 | 2013 | 24315 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1104 | 0.040 |
Why?
|
Indoles | 1 | 2008 | 1836 | 0.040 |
Why?
|
Breast Neoplasms | 4 | 2009 | 21206 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2007 | 985 | 0.040 |
Why?
|
Accreditation | 1 | 2023 | 476 | 0.040 |
Why?
|
Posture | 1 | 2004 | 957 | 0.040 |
Why?
|
Radiotherapy Dosage | 2 | 2021 | 2916 | 0.040 |
Why?
|
Tumor Burden | 2 | 2020 | 1906 | 0.040 |
Why?
|
Appendicitis | 2 | 2003 | 690 | 0.040 |
Why?
|
Safety | 1 | 2004 | 1159 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2023 | 990 | 0.040 |
Why?
|
Organs at Risk | 1 | 2021 | 367 | 0.040 |
Why?
|
Sciatic Nerve | 1 | 2002 | 628 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1401 | 0.040 |
Why?
|
Radionuclide Imaging | 3 | 2012 | 2000 | 0.040 |
Why?
|
Echo-Planar Imaging | 1 | 2022 | 648 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 1140 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1489 | 0.040 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1998 | 64 | 0.040 |
Why?
|
Pancreatitis | 1 | 2005 | 1087 | 0.040 |
Why?
|
Laparotomy | 1 | 2020 | 458 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2004 | 1196 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1616 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2005 | 1099 | 0.040 |
Why?
|
Mutation | 2 | 2020 | 30238 | 0.040 |
Why?
|
Splenic Vein | 1 | 1997 | 30 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 40218 | 0.040 |
Why?
|
Esophageal Achalasia | 1 | 1998 | 98 | 0.030 |
Why?
|
Pregnancy | 6 | 2016 | 30256 | 0.030 |
Why?
|
Radiotherapy | 1 | 2003 | 1502 | 0.030 |
Why?
|
Laparoscopy | 2 | 2024 | 2041 | 0.030 |
Why?
|
Catheter Ablation | 1 | 2010 | 2780 | 0.030 |
Why?
|
Carcinoma, Papillary | 1 | 2002 | 793 | 0.030 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1885 | 0.030 |
Why?
|
Edetic Acid | 1 | 1997 | 278 | 0.030 |
Why?
|
Arthritis, Infectious | 1 | 2000 | 348 | 0.030 |
Why?
|
Artifacts | 2 | 2015 | 1926 | 0.030 |
Why?
|
Pregnancy, High-Risk | 1 | 2016 | 121 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14783 | 0.030 |
Why?
|
Protons | 1 | 2021 | 1113 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2004 | 1536 | 0.030 |
Why?
|
Equipment Design | 1 | 2004 | 3522 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2017 | 248 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2004 | 1457 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2005 | 1382 | 0.030 |
Why?
|
Health Care Costs | 1 | 2008 | 3239 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2267 | 0.030 |
Why?
|
Chelating Agents | 1 | 1997 | 385 | 0.030 |
Why?
|
Fatal Outcome | 2 | 2011 | 1836 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2005 | 1402 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2021 | 802 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2010 | 4310 | 0.030 |
Why?
|
Logistic Models | 1 | 2009 | 13290 | 0.030 |
Why?
|
Critical Pathways | 1 | 2018 | 476 | 0.030 |
Why?
|
Proteus mirabilis | 1 | 2014 | 24 | 0.030 |
Why?
|
Hematinics | 1 | 2017 | 282 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2005 | 5315 | 0.030 |
Why?
|
Job Description | 1 | 2014 | 61 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2014 | 363 | 0.030 |
Why?
|
Phenotype | 1 | 2012 | 16726 | 0.030 |
Why?
|
Reproductive Medicine | 1 | 2015 | 99 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1737 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2018 | 1497 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1900 | 0.030 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2000 | 843 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4627 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2005 | 2043 | 0.030 |
Why?
|
Emergencies | 1 | 2018 | 1221 | 0.020 |
Why?
|
Exons | 1 | 2018 | 2394 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2023 | 4541 | 0.020 |
Why?
|
Polymyositis | 1 | 2011 | 75 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2062 | 0.020 |
Why?
|
Nomograms | 1 | 2013 | 236 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2020 | 2167 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2006 | 15948 | 0.020 |
Why?
|
Drug Combinations | 1 | 1997 | 2089 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3347 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2009 | 3556 | 0.020 |
Why?
|
Ribs | 1 | 2012 | 259 | 0.020 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2010 | 204 | 0.020 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2010 | 190 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2004 | 5341 | 0.020 |
Why?
|
Regression Analysis | 2 | 2012 | 6340 | 0.020 |
Why?
|
Diatrizoate Meglumine | 1 | 2008 | 79 | 0.020 |
Why?
|
Connective Tissue Diseases | 1 | 2011 | 285 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2002 | 2360 | 0.020 |
Why?
|
Anesthesia, Local | 1 | 2010 | 278 | 0.020 |
Why?
|
Decision Making | 2 | 2013 | 3953 | 0.020 |
Why?
|
Fluoroscopy | 2 | 2005 | 947 | 0.020 |
Why?
|
Patient Positioning | 1 | 2010 | 332 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.020 |
Why?
|
Skull | 1 | 2012 | 820 | 0.020 |
Why?
|
Recurrence | 2 | 2010 | 8509 | 0.020 |
Why?
|
Immunotherapy | 1 | 2023 | 4755 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5349 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 979 | 0.020 |
Why?
|
Liposomes | 1 | 2010 | 790 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6229 | 0.020 |
Why?
|
Cystectomy | 1 | 2011 | 603 | 0.020 |
Why?
|
North America | 1 | 2010 | 1289 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2010 | 5536 | 0.020 |
Why?
|
Double-Blind Method | 2 | 1999 | 12465 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5100 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2014 | 1276 | 0.020 |
Why?
|
Axilla | 1 | 2008 | 623 | 0.020 |
Why?
|
Drug Carriers | 1 | 2010 | 709 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2014 | 2512 | 0.020 |
Why?
|
Microcirculation | 1 | 2010 | 1281 | 0.020 |
Why?
|
Conscious Sedation | 1 | 2010 | 534 | 0.020 |
Why?
|
Body Mass Index | 1 | 2003 | 13053 | 0.020 |
Why?
|
Mice, SCID | 1 | 2010 | 2627 | 0.020 |
Why?
|
Groin | 1 | 2005 | 106 | 0.020 |
Why?
|
Thyroid Gland | 1 | 2011 | 1171 | 0.010 |
Why?
|
Infant | 2 | 2023 | 36535 | 0.010 |
Why?
|
Subphrenic Abscess | 1 | 2004 | 22 | 0.010 |
Why?
|
Esophagectomy | 1 | 2008 | 481 | 0.010 |
Why?
|
Hydronephrosis | 1 | 2006 | 274 | 0.010 |
Why?
|
Area Under Curve | 1 | 2008 | 1643 | 0.010 |
Why?
|
Bile | 1 | 2005 | 299 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 5047 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2010 | 1741 | 0.010 |
Why?
|
Life Expectancy | 1 | 2010 | 1248 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3436 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1791 | 0.010 |
Why?
|
Kinetics | 1 | 2010 | 6329 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2298 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2010 | 1930 | 0.010 |
Why?
|
Models, Structural | 1 | 2002 | 340 | 0.010 |
Why?
|
Postoperative Care | 1 | 2008 | 1480 | 0.010 |
Why?
|
Adrenal Gland Diseases | 1 | 2003 | 141 | 0.010 |
Why?
|
Surgical Instruments | 1 | 2004 | 381 | 0.010 |
Why?
|
Ureteral Obstruction | 1 | 2003 | 293 | 0.010 |
Why?
|
Monocytes | 1 | 2010 | 2605 | 0.010 |
Why?
|
Cholecystitis | 1 | 2002 | 181 | 0.010 |
Why?
|
Phlebography | 1 | 2002 | 326 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26422 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6283 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
Device Removal | 1 | 2005 | 643 | 0.010 |
Why?
|
Angiography | 1 | 2005 | 1597 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42669 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7951 | 0.010 |
Why?
|
Animals | 3 | 2017 | 169246 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4055 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4260 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6526 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10632 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 2004 | 715 | 0.010 |
Why?
|
Barium Sulfate | 1 | 1998 | 180 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9495 | 0.010 |
Why?
|
Neck | 1 | 2002 | 736 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 13045 | 0.010 |
Why?
|
Videotape Recording | 1 | 1998 | 335 | 0.010 |
Why?
|
Mastectomy | 1 | 2005 | 1861 | 0.010 |
Why?
|
Gestational Age | 1 | 2005 | 3621 | 0.010 |
Why?
|
Tomography, Optical Coherence | 1 | 2009 | 2957 | 0.010 |
Why?
|
Manometry | 1 | 1998 | 459 | 0.010 |
Why?
|
Macrophages | 1 | 2010 | 5799 | 0.010 |
Why?
|
Lung | 1 | 2014 | 10099 | 0.010 |
Why?
|
Administration, Oral | 1 | 2003 | 4030 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18412 | 0.010 |
Why?
|
Reoperation | 1 | 2005 | 4329 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2004 | 6847 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12543 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1997 | 2230 | 0.010 |
Why?
|
Melanoma | 1 | 2010 | 5706 | 0.010 |
Why?
|
Obesity | 1 | 2012 | 13090 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2709 | 0.010 |
Why?
|
Stroke | 1 | 2011 | 9755 | 0.010 |
Why?
|
Neurons | 1 | 2008 | 9514 | 0.000 |
Why?
|
Chronic Disease | 1 | 2003 | 9384 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13676 | 0.000 |
Why?
|
Mice | 1 | 2010 | 82029 | 0.000 |
Why?
|